Neuberger Berman Group’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-19,193
Closed -$319K 1672
2017
Q4
$319K Hold
19,193
﹤0.01% 1525
2017
Q3
$328K Hold
19,193
﹤0.01% 1395
2017
Q2
$311K Buy
+19,193
New +$303K ﹤0.01% 1404

Other funds holding ANGO

Neuberger Berman Group's ANGO Position: Q1 2018 in Review

Neuberger Berman Group sold out of AngioDynamics (ANGO) in Q1 2018, closing a stake of 19,193 shares — an estimated $319K sold.

Neuberger Berman Group first reported a position in ANGO in Q2 2017 and held it in 3 quarters. The position peaked at $328K in Q3 2017. 164 funds tracked by Wall St. Rank hold ANGO as of Q1 2018.

  • Neuberger Berman Group reported no remaining AngioDynamics position as of Q1 2018 after selling out during the quarter.
  • Neuberger Berman Group sold 19,193 AngioDynamics shares in Q1 2018, an estimated $319K.
  • Neuberger Berman Group first reported a position in AngioDynamics in Q2 2017 and held it in 3 quarters.
  • Neuberger Berman Group's AngioDynamics position peaked at $328K in Q3 2017.
  • 164 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2018.

Based on Neuberger Berman Group's 13F filing for Q1 2018, filed 8 May 2018.